CN103655875B - Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis - Google Patents
Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis Download PDFInfo
- Publication number
- CN103655875B CN103655875B CN201310679983.1A CN201310679983A CN103655875B CN 103655875 B CN103655875 B CN 103655875B CN 201310679983 A CN201310679983 A CN 201310679983A CN 103655875 B CN103655875 B CN 103655875B
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- medicine
- patients
- aplastic anemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses the medicine that treatment blood sampling causes Patients with Aplastic Anemia venous thrombosis, medicine of the present invention is made up of following component: Caulis Polygoni Multiflori 20 grams of Arillus Longans 30 grams of Semen Ziziphi Spinosaes 12 grams of Ramulus Cinnamomi 12 grams of Rhizoma Atractylodis 12 grams of Radix Polygalaes 6 grams of Rhizoma Acori Graminei 18 grams of Herba Ephedraes 15 grams of Cortex Mori 10 grams of Sargassums 45 grams of Folium Pyrrosiaes 10 grams; Above-mentioned each component mix homogeneously is ground into 180 order fine powders, every day twice for oral administration, each 10 grams, warm water delivery service.It within three months, is a course for the treatment of.
Description
Technical field the invention belongs to technical field of Chinese medicines, and relating to the medicine for the treatment of blood sampling and causing Patients with Aplastic Anemia venous thrombosis, is medicine prepared by raw material specifically with Chinese herbal medicine.
The doctor of background technology clinical laboratory often runs into because long term frequent aculeus blood-taking causes aplastic poor patient's acra venous thrombosis person in blood sampling work, general treatment because of the method for Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample be take the traditional methods such as enteric coated aspirin, but the method still makes the venous thrombosis of a lot of Patients with Aplastic Anemia and can not recover, this is because Patients with Aplastic Anemia hemopoietic function is abnormal and cause blood coagulation abnormal, so therapeutic effect is undesirable; We find Chinese medicine at work to treatment because the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample has good curative effect, cause the medicine of Patients with Aplastic Anemia venous thrombosis to be very required so utilize the advantage of Chinese medicine to invent treatment blood sampling.
Summary of the invention the object of this invention is to provide the medicine that treatment blood sampling causes Patients with Aplastic Anemia venous thrombosis, to overcome the deficiencies in the prior art.
The object of the invention is according to traditional medicine pathogenetic understanding of this disease of Patients with Aplastic Anemia venous thrombosis caused because of blood sampling and Therapeutic Principle thereof, therefrom filtering out treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis to form and repair the natural Chinese medicinal herb of the blood vessel endothelium that acupuncture causes, make drug powder by theory of Chinese medical science prescription, make it play the effect for the treatment of because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample.
Medicine of the present invention is the drug powder be made up of the crude drug of following weight proportioning.
Medicine of the present invention is made up of following component:
Caulis Polygoni Multiflori 20 grams of Arillus Longans 30 grams of Semen Ziziphi Spinosaes 12 grams of Ramulus Cinnamomi 12 grams of Rhizoma Atractylodis 12 grams of Radix Polygalaes 6 grams of Rhizoma Acori Graminei 18 grams of Herba Ephedraes 15 grams of Cortex Mori 10 grams of Sargassums 45 grams of Folium Pyrrosiaes 10 grams
Above-mentioned each component mix homogeneously is ground into 180 order fine powders, every day twice for oral administration, each 10 grams, warm water delivery service.It within three months, is a course for the treatment of.
Medicine of the present invention is Chinese medicine preparation, select medicine rationally, treating both the principal and secondary aspects of a disease.Medicine of the present invention, through clinical observation patient for many years, evident in efficacy, there is remarkable result to because of the Patients with Aplastic Anemia venous thrombosis patient caused that takes a blood sample.
Clinical drug of the present invention is taken result and is shown, has following advantage:
The present invention selects natural plant, and each component meets pharmaceutical control law regulation, utilizes the comprehensive function of each taste medicine to treat because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample, without chemicals, harmless to human non-toxic, have no side effect, safe and reliable, curative effect is high, cheap, without any discomfort disease.
The present invention selects natural plant to be raw material, and each component meets pharmaceutical control law regulation, utilizes the comprehensive function of each taste medicine to treat because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample, harmless to human non-toxic, has no side effect, safe and reliable; The present invention is that powder takes orally, and effective ingredient scatters and disappears few, and curative effect is high, cheap, easy to use, without any discomfort disease; Medicine of the present invention is obvious to the Patients with Aplastic Anemia venous thrombosis curative effect caused because taking a blood sample; Clinical drug of the present invention is observed, and can replace conventional medicament (enteric coated aspirin) treatment because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample.
For showing that medicine of the present invention is to the therapeutic effect because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample, the patient that the present invention suffers from through the long-term blood sampling of 600 example because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample does the clinical observation of system for treatment group, and patient 600 example because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample selecting medical history, the state of an illness, age and traditional therapy suitable as a control group, age 16-60 year, the course of disease 6 months-12 months.Treatment group: conventional medicine (enteric coated aspirin) of stopping using, takes drug powder of the present invention; Matched group: take traditional conventional medicine (enteric coated aspirin), the observation period is 1 month, checked after one month.Efficacy assessment standard adopts in People's Republic of China's traditional Chinese medicine industry standard in 2010 " disease of tcm Standardization of diagnosis and curative effect ".Acra vein blood vessel is unobstructed and do not have obvious thrombosis person for effective (evident in efficacy), acra vein blood vessel is logical and impassable patient (namely having blood flow pass through but still have remaining thrombosis in vein blood vessel in vein blood vessel) is effective, and acra blood vessel complete thromboembolism person is invalid.
Clinical trial results is in table 1.
Table 1: take medicine group of the present invention and the observation of curative effect taking conventional medicine group.
Note: comparitive study adopts statistical method, enumeration data adopts X
2inspection, two groups of effective percentage compare P < 0.01
As can be seen from Table 1, medicine of the present invention is to the treatment group of 600 examples because of the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample, and what obtain significant curative effect has 340 examples; Effectively there are 200 examples, account for 32.0%; Total effective rate reaches 90%, and matched group is 20%, and treatment group is obviously better than matched group (P < 0.01), namely takes medicine of the present invention to treatment because the Patients with Aplastic Anemia venous thrombosis caused of taking a blood sample has significant therapeutic effect.
Detailed description of the invention
Raw material is chosen by following proportioning:
Caulis Polygoni Multiflori 20 grams of Arillus Longans 30 grams of Semen Ziziphi Spinosaes 12 grams of Ramulus Cinnamomi 12 grams of Rhizoma Atractylodis 12 grams of Radix Polygalaes 6 grams of Rhizoma Acori Graminei 18 grams of Herba Ephedraes 15 grams of Cortex Mori 10 grams of Sargassums 45 grams of Folium Pyrrosiaes 10 grams
Above-mentioned each component mix homogeneously is ground into 180 order fine powders, every day twice for oral administration, each 10 grams, warm water delivery service.It within three months, is a course for the treatment of.
Claims (1)
1. treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis, it is characterized in that the powder be made up of the raw material of following weight proportioning: Caulis Polygoni Multiflori 20 parts, Arillus Longan 30 parts, Semen Ziziphi Spinosae 12 parts, Ramulus Cinnamomi 12 parts, Rhizoma Atractylodis 12 parts, Radix Polygalae 6 parts, Rhizoma Acori Graminei 18 parts, 15 parts, Herba Ephedrae, Cortex Mori 10 parts, Sargassum 45 parts, Folium Pyrrosiae 10 parts; Above-mentioned each component mix homogeneously is ground into 180 order fine powders and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310679983.1A CN103655875B (en) | 2013-12-07 | 2013-12-07 | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310679983.1A CN103655875B (en) | 2013-12-07 | 2013-12-07 | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103655875A CN103655875A (en) | 2014-03-26 |
| CN103655875B true CN103655875B (en) | 2015-09-23 |
Family
ID=50295434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310679983.1A Expired - Fee Related CN103655875B (en) | 2013-12-07 | 2013-12-07 | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103655875B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181600A (en) * | 2007-11-20 | 2008-05-21 | 王振才 | Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
-
2013
- 2013-12-07 CN CN201310679983.1A patent/CN103655875B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181600A (en) * | 2007-11-20 | 2008-05-21 | 王振才 | Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
Non-Patent Citations (1)
| Title |
|---|
| 施今墨的临床经验;《首都医药》;20050701(第07期) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103655875A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN101954042A (en) | Tumor eliminating capsule | |
| CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN104491684A (en) | Traditional Chinese medicine for treating insomnia and application thereof | |
| CN103893601B (en) | A kind of medicament for the treatment of mumps | |
| CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN105535849A (en) | Traditional Chinese medicine for treating liver depression insomnia | |
| CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
| CN104800799A (en) | Traditional Chinese medicament for treating endometrial thickening with ovarian cysts | |
| CN103356840A (en) | Medicament for treating cold | |
| CN103463444B (en) | Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes | |
| CN102526622B (en) | Medicine for treating knee-joint bursitis | |
| CN102552570B (en) | Medicine for treating acra necrosis after bone trauma | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN103230484B (en) | Drug for treating knee osteoarthritis of patients under age of 40 | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
| CN105535817A (en) | A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof | |
| CN104887874A (en) | Traditional Chinese medicine composition for treating pneumonia | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150923 Termination date: 20151207 |
|
| EXPY | Termination of patent right or utility model |